{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:56Z","timestamp":1787026496857,"version":"build-2736575974"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Accumulating evidence support that mannan-binding lectin (MBL) is a promising prognostic biomarker for risk-stratification of diabetic micro- and macrovascular complications. Serum MBL levels are predominately genetically determined and depend on MBL genotype. However, Type 1 diabetes (T1D) is associated with higher MBL serum levels for a given MBL genotype, but it remains unknown if this is also the case for patients with T2D. In this study, we evaluated the impact of MBL genotypes on renal function trajectories serum MBL levels and compared MBL genotypes in newly diagnosed patients with T2D with age- and sex-matched healthy individuals. Furthermore, we evaluated differences in parameters of insulin resistance within MBL genotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a cross-sectional study, we included 100 patients who were recently diagnosed with T2D and 100 age- and sex-matched individuals. We measured serum MBL levels, MBL genotype, standard biochemistry, and DEXA, in all participants. A 5-year clinical follow-up study was conducted, followed by 12-year data on follow-up biochemistry and clinical status for the progression to micro- or macroalbuminuria for the patients with T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found similar serum MBL levels and distribution of MBL genotypes between T2D patients and healthy individuals. The serum MBL level for a given MBL genotype did not differ between the groups neither at study entry nor at 5-year follow-up. We found that plasma creatinine increased more rapidly in patients with T2D with the high MBL expression genotype than with the medium\/low MBL expression genotype over the 12-year follow-up period (p = 0.029). Serum MBL levels did not correlate with diabetes duration nor with HbA1c. Interestingly, serum MBL was inversely correlated with body fat percentage in individuals with high MBL expression genotypes both at study entry (p=0.0005) and 5-years follow-up (p=0.002).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      Contrary to T1D, T2D is not\n                      <jats:italic>per se<\/jats:italic>\n                      associated with increased MBL serum level for a given MBL genotype or with diabetes duration. Serum MBL was inversely correlated with body fat percentage, and T2D patients with the high MBL expression genotype presented with deterioration of renal function.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2022.1080388","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:02:25Z","timestamp":1671757345000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["High MBL-expressing genotypes are associated with deterioration in renal function in type 2 diabetes"],"prefix":"10.3389","volume":"13","author":[{"given":"G. H.","family":"D\u00f8rflinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"H\u00f8yem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Laugesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. L.","family":"Funck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. L.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. K.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bjerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-861372","article-title":"Mannose-binding lectin (MBL) and vascular complications in diabetes","author":"Hansen","year":"2005","journal-title":"Horm Metab Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrendo.2009.266","article-title":"Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily","volume":"6","author":"Flyvbjerg","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/386506a0","article-title":"A second serine protease associated with mannan-binding lectin that activates complement","volume":"386","author":"Thiel","year":"1997","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1079","article-title":"Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes","volume":"26","author":"Fortpied","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/sj.gene.6364283","article-title":"Mannose-binding lectin and its genetic variants","volume":"7","author":"Garred","year":"2006","journal-title":"Genes Immun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0022-1759(00)00198-8","article-title":"Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers","volume":"241","author":"Steffensen","year":"2000","journal-title":"J Immunol Methods"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.6.3013","article-title":"Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein","volume":"155","author":"Madsen","year":"1995","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.03.015","article-title":"Mannan-binding lectin\u2013a soluble pattern recognition molecule","volume":"41","author":"Gadjeva","year":"2004","journal-title":"Mol Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.6.1570","article-title":"Association between mannose-binding lectin and vascular complications in type 1 diabetes","volume":"53","author":"Hansen","year":"2004","journal-title":"Diabetes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1495","article-title":"Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy","volume":"58","author":"Kaunisto","year":"2009","journal-title":"Diabetes"},{"key":"B11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00125-004-1594-1","article-title":"Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy","volume":"48","author":"Saraheimo","year":"2005","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030742","article-title":"Elevated levels of mannan-binding lectin in patients with type 1 diabetes","volume":"88","author":"Hansen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0851","article-title":"Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study","volume":"38","author":"Ostergaard","year":"2015","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21861","article-title":"Mannose-binding lectin and diabetic nephropathy in type 1 diabetes","volume":"30","author":"Zhao","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119699","article-title":"Elevated serum levels of mannose-binding lectin and diabetic nephropathy in type 2 diabetes","volume":"10","author":"Guan","year":"2015","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0345","article-title":"Mannose-binding lectin and risk of cardiovascular events and mortality in type 2 diabetes: A Danish cohort study","volume":"43","author":"Gedebjerg","year":"2020","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-1872","article-title":"Insulin resistance is associated with decreased circulating mannan-binding lectin concentrations in women with polycystic ovary syndrome","volume":"31","author":"Kowalska","year":"2008","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0381-6","article-title":"Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectin","volume":"49","author":"Fernandez-Real","year":"2006","journal-title":"Diabetologia"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.10.3002","article-title":"Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles","volume":"54","author":"Bouwman","year":"2005","journal-title":"Diabetes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12027","article-title":"Diabetes-induced changes in mannan-binding lectin levels and complement activation in a mouse model of type 1 diabetes","volume":"77","author":"Ostergaard","year":"2013","journal-title":"Scand J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.18.2007","article-title":"Mannose-binding lectin and mortality in type 2 diabetes","volume":"166","author":"Hansen","year":"2006","journal-title":"Arch Intern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0942","article-title":"Carotid-femoral pulse wave velocity is associated with cerebral white matter lesions in type 2 diabetes","volume":"36","author":"Laugesen","year":"2013","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001308","article-title":"Increased high-risk coronary plaque burden is associated with arterial stiffness in patients with type 2 diabetes without clinical signs of coronary artery disease: a computed tomography angiography study","volume":"35","author":"Funck","year":"2017","journal-title":"J Hypertens"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00145","article-title":"Assays for the functional activity of the mannan-binding lectin pathway of complement activation","volume":"205","author":"Thiel","year":"2002","journal-title":"Immunobiology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/cei.13315","article-title":"Circulating lectin pathway proteins do not predict short-term cardiac outcomes after myocardial infarction","volume":"198","author":"Holt","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1600-0609.2010.01443.x","article-title":"Sepsis in acute myeloid leukaemia patients receiving high-dose chemotherapy: no impact of chitotriosidase and mannose-binding lectin polymorphisms","volume":"85","author":"Klostergaard","year":"2010","journal-title":"Eur J Haematol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Internal Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13098-021-00691-y","article-title":"Arterial stiffness and progression of cerebral white matter hyperintensities in patients with type 2 diabetes and matched controls: a 5-year cohort study","volume":"13","author":"Funck","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040111","article-title":"A population-based study of morbidity and mortality in mannose-binding lectin deficiency","volume":"199","author":"Dahl","year":"2004","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0903","article-title":"Mannose-binding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial","volume":"33","author":"Mellbin","year":"2010","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03101.x","article-title":"Hormonal regulation of mannan-binding lectin synthesis in hepatocytes","volume":"145","author":"Sorensen","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0960","article-title":"Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women","volume":"92","author":"Manco","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"354894","DOI":"10.1155\/2012\/354894","article-title":"The effect of weight loss on serum mannose-binding lectin levels","volume":"2012","author":"Hoyem","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00299.2011","article-title":"Plasma mannose-binding lectin is stimulated by PPARalpha in humans","volume":"302","author":"Rakhshandehroo","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications\u2013a review","volume":"13","author":"Grygiel-Gorniak","year":"2014","journal-title":"Nutr J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1186\/s12967-020-02310-2","article-title":"Mannose-binding lectin activation is associated with the progression of diabetic nephropathy in type 2 diabetes mellitus patients","volume":"8","author":"Cai","year":"2020","journal-title":"Ann Transl Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cca.2018.03.033","article-title":"Lectin-induced renal local complement activation is involved in tubular interstitial injury in diabetic nephropathy","volume":"482","author":"Zheng","year":"2018","journal-title":"Clin Chim Acta"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.04.001","article-title":"Complement activation in patients with diabetic nephropathy","volume":"45","author":"Li","year":"2019","journal-title":"Diabetes Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy034","article-title":"Mannose-binding lectin genotypes and outcome in end-stage renal disease: a prospective cohort study","volume":"33","author":"Adrian","year":"2018","journal-title":"Nephrol Dial Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1080388\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:02:28Z","timestamp":1671757348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1080388\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2022.1080388"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1080388","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]},"article-number":"1080388"}}